Apellis Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-14.97 | -284.59 | -94.74% | -11.17 | +34.03% |
| P/S |
|
5.06 | 60.36 | -91.62% |
|
|
| P/BV |
|
17.29 | 262.42 | -93.41% |
|
|
| P/FCF |
|
-33.55 | -202.12 | -83.4% |
|
|
| Ev/Ebitda |
|
-25.96 | 11.97 | -316.84% |
|
|
| Ev/S |
|
5.13 | 478.5 | -98.93% |
|
|
| Ev/FCF |
|
-45.44 | -243.43 | -81.33% |
|
|
| E/P |
|
-0.0668 | 0.0228 | -393.41% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-19.78 | -382.73 | -94.83% | -356.75 | -94.46% |
| ROE |
|
-93.55 | 105.9 | -188.33% |
|
|
| ROA |
|
-23.64 | -2.97 | 696.7% |
|
|
| ROIC |
|
-121.89 | 0.8343 | -14710.34% |
|
|
| ROS |
|
-25.32 | -305.7 | -91.72% |
|
|
| ROCE |
|
-68.4 | 3.06 | -2336.15% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-3.04 | 0.9443 | -421.95% | -1.35 | +124.39% |
| Nеt Debt/Ebitda |
|
-0.3785 | 1.01 | -137.51% |
|
|
| Debt/Ratio |
|
0.5308 | 0.1792 | 196.26% |
|
|
| Debt/Equity |
|
2.87 | 1.61 | 78.13% |
|
|
| Debt/Net Income |
|
-2.37 | -1.68 | 41.19% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5148 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8864 | -100% | ||
| DSI |
|
0 | 0.2033 | -100% |
|
|
| Average dividend growth |
|
0 | 1.93 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5087 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.41 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5148 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
211.8 | -99.58 | -312.69% | ||
| Growth impulse Ebitda in 5 years |
|
-26.2 | -152.61 | -82.83% | ||
| Growth impulse Net Income in 5 years |
|
-42.63 | -108.17 | -60.59% | ||
| Growth impulse FCF in 5 years |
|
-46.79 | -131.02 | -64.29% | ||
| Growth impulse EPS in 5 years |
|
-65.21 | -103.17 | -36.79% |
IP Score
2.69/10
